Leekitcharoenphon, Pimlapas
Johansson, Markus Hans Kristofer
Munk, Patrick
Malorny, Burkhard
Skarżyńska, Magdalena
Wadepohl, Katharina
Moyano, Gabriel
Hesp, Ayla
Veldman, Kees T.
Bossers, Alex
Graveland, Haitske
van Essen, Alieda
Battisti, Antonio
Caprioli, Andrea
Blaha, Thomas
Hald, Tine
Daskalov, Hristo
Saatkamp, Helmut W.
Stärk, Katharina D. C.
Luiken, Roosmarijn E. C.
Van Gompel, Liese
Hansen, Rasmus Borup
Dewulf, Jeroen
Duarte, Ana Sofia Ribeiro
Zając, Magdalena
Wasyl, Dariusz
Sanders, Pascal
Gonzalez-Zorn, Bruno
Brouwer, Michael S. M.
Wagenaar, Jaap A.
Heederik, Dick J. J.
Mevius, Dik
Aarestrup, Frank M.
,
Funding for this research was provided by:
The Novo Nordisk Foundation (NNF16OC0021856, NNF16OC0021856, NNF16OC0021856)
the European Union-funded EFFORT project (613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754, 613754)
EJP-one health project Full-force (773830, 773830)
Article History
Received: 11 January 2021
Accepted: 5 July 2021
First Online: 23 July 2021
Competing interests
: The authors declare no competing interests.